The German medical devices industry is continuing to lobby against a requirement in the forthcoming revision to the Medical Devices Act (MPG) that would require manufacturers to have their clinical trials authorised by the Federal Institute for Drugs and Medical Devices (BfArM)1,2...
Please login to read the full article.
